A 60-year-old Danish woman who succumbed to a blood clot after receiving a vaccine developed by AstraZeneca had a “highly unusual” disease state, according to the Danish Medicines Agency.
A 60-year-old Danish woman who succumbed to a blood clot after receiving a vaccine developed by AstraZeneca had a “highly unusual” disease state, according to the Danish Medicines Agency.
